Grifols (GRFS) Change in Working Capital (2010 - 2016)

Grifols (GRFS) reported Change in Working Capital of $52.9 million for Q4 2016, up 138.84% on a YoY basis from $22.2 million in Q1 2016, and up 22.98% quarter-over-quarter from $43.0 million in Q3 2016.

Grifols (GRFS) Change in Working Capital (2010 - 2016) Analysis & Trends

Grifols has reported Change in Working Capital for 6 years, with the latest figure at $52.9 million in Q4 2016.

  • For the quarter ending Q4 2016, Change in Working Capital rose 138.84% year-over-year to $52.9 million; the trailing twelve-month figure through Dec 2016 stood at $46.9 million (down 46.73% YoY), and the FY2025 full-year result was $36.1 million, down 95.46% from the prior year.
  • Change in Working Capital for Q4 2016 stood at $52.9 million, up from $43.0 million in the prior quarter.
  • The five-year high for Change in Working Capital was $160.4 million in Q2 2012, with the low at -$136.3 million in Q4 2015.
  • Historically, Change in Working Capital has averaged $56.6 million across 4 years, with a median of $78.0 million in 2012.
  • Annual changes were most pronounced in 2012 — Change in Working Capital slumped 84.92% — and 2013, when it soared 109931.64%.
  • Grifols' Change in Working Capital stood at $109.7 million in 2012, then slipped by 17.35% to $90.6 million in 2013, then slumped by 250.37% to -$136.3 million in 2015, then soared by 138.84% to $52.9 million in 2016.
  • The last three Change in Working Capital figures came in at $52.9 million (Q4 2016), $43.0 million (Q3 2016), and -$136.3 million (Q4 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn -
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn -
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Grifols 6.05 Bn 5.09 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 52.93 Mn
Dec 31, 2016 52.93 Mn
Sep 30, 2016 43.04 Mn
Sep 30, 2016 43.04 Mn
Dec 31, 2015 -136.30 Mn
Dec 31, 2015 -136.30 Mn
Sep 30, 2015 87.24 Mn
Sep 30, 2015 87.24 Mn
Jun 30, 2015 80.32 Mn
Jun 30, 2015 80.32 Mn
Mar 31, 2015 56.82 Mn
Mar 31, 2015 56.82 Mn
Mar 31, 2013 90.64 Mn
Mar 31, 2013 90.64 Mn
Dec 31, 2012 109.67 Mn
Dec 31, 2012 109.67 Mn
Sep 30, 2012 77.98 Mn
Sep 30, 2012 77.98 Mn
Jun 30, 2012 160.42 Mn
Jun 30, 2012 160.42 Mn